Tags

Type your tag names separated by a space and hit enter

Association between cigarette smoking and Parkinson's disease: A meta-analysis.
Arch Gerontol Geriatr. 2015 Nov-Dec; 61(3):510-6.AG

Abstract

OBJECTIVE

To evaluate the association of Parkinson's disease (PD) with smoking, and determine whether gender, source of controls, dose of smoking, and year of studies modify the observed effects of smoking on PD.

METHODS

Available publications between 1959 and 2014 from PubMed, ScienceDirect, Springer Link and Web of Science databases were searched and carefully selected. Relative risks RR of specific study were weighted to obtain a pooled RR estimate and its 95% confidence interval CI.

RESULTS

61 case-control and 8 cohort studies were included. The pooled RR of PD was 0.59 (95% CI, 0.56-0.62) for ever smokers compared with never smokers. The stratified analyses indicated a somewhat greater impact of smoking on PD risk in cohort studies than in case-control studies, the protective effect was relatively significant in men more than in women and the inverse effect was slightly greater in hospital-based studies than in population-based studies. Furthermore, a significant inverse dose-response relationship was observed for the number of pack-years smoked. The summary RR for those smoking more than 30 pack-years was 0.66 (95% CI, 0.49-0.88), and 0.39 (95% CI, 0.29-0.53) for those smoking less than 30 pack-years.

CONCLUSION

The results demonstrated the inverse association between cigarette smoking and the risk of PD. We suggest that effective drugs for PD might be developed using chemical substances derived from tobacco or tobacco smoke.

Authors+Show Affiliations

Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China. Electronic address: ytang234@ecust.edu.cn.

Pub Type(s)

Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

26272284

Citation

Li, Xiao, et al. "Association Between Cigarette Smoking and Parkinson's Disease: a Meta-analysis." Archives of Gerontology and Geriatrics, vol. 61, no. 3, 2015, pp. 510-6.
Li X, Li W, Liu G, et al. Association between cigarette smoking and Parkinson's disease: A meta-analysis. Arch Gerontol Geriatr. 2015;61(3):510-6.
Li, X., Li, W., Liu, G., Shen, X., & Tang, Y. (2015). Association between cigarette smoking and Parkinson's disease: A meta-analysis. Archives of Gerontology and Geriatrics, 61(3), 510-6. https://doi.org/10.1016/j.archger.2015.08.004
Li X, et al. Association Between Cigarette Smoking and Parkinson's Disease: a Meta-analysis. Arch Gerontol Geriatr. 2015 Nov-Dec;61(3):510-6. PubMed PMID: 26272284.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Association between cigarette smoking and Parkinson's disease: A meta-analysis. AU - Li,Xiao, AU - Li,Weihua, AU - Liu,Guixia, AU - Shen,Xu, AU - Tang,Yun, Y1 - 2015/08/04/ PY - 2014/12/20/received PY - 2015/07/30/revised PY - 2015/08/01/accepted PY - 2015/8/15/entrez PY - 2015/8/15/pubmed PY - 2016/2/16/medline KW - Cigarette smoking KW - Meta-analysis KW - Pack-year KW - Parkinson’s disease SP - 510 EP - 6 JF - Archives of gerontology and geriatrics JO - Arch Gerontol Geriatr VL - 61 IS - 3 N2 - OBJECTIVE: To evaluate the association of Parkinson's disease (PD) with smoking, and determine whether gender, source of controls, dose of smoking, and year of studies modify the observed effects of smoking on PD. METHODS: Available publications between 1959 and 2014 from PubMed, ScienceDirect, Springer Link and Web of Science databases were searched and carefully selected. Relative risks RR of specific study were weighted to obtain a pooled RR estimate and its 95% confidence interval CI. RESULTS: 61 case-control and 8 cohort studies were included. The pooled RR of PD was 0.59 (95% CI, 0.56-0.62) for ever smokers compared with never smokers. The stratified analyses indicated a somewhat greater impact of smoking on PD risk in cohort studies than in case-control studies, the protective effect was relatively significant in men more than in women and the inverse effect was slightly greater in hospital-based studies than in population-based studies. Furthermore, a significant inverse dose-response relationship was observed for the number of pack-years smoked. The summary RR for those smoking more than 30 pack-years was 0.66 (95% CI, 0.49-0.88), and 0.39 (95% CI, 0.29-0.53) for those smoking less than 30 pack-years. CONCLUSION: The results demonstrated the inverse association between cigarette smoking and the risk of PD. We suggest that effective drugs for PD might be developed using chemical substances derived from tobacco or tobacco smoke. SN - 1872-6976 UR - https://www.unboundmedicine.com/medline/citation/26272284/Association_between_cigarette_smoking_and_Parkinson's_disease:_A_meta_analysis_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0167-4943(15)30036-4 DB - PRIME DP - Unbound Medicine ER -